Randomised controlled trial of integrated cognitive behavioural treatment and motivational enhancement for comorbid social anxiety and alcohol use disorders.

Cognitive behavioural treatment alcohol use disorder comorbidity motivational enhancement social anxiety

Journal

The Australian and New Zealand journal of psychiatry
ISSN: 1440-1614
Titre abrégé: Aust N Z J Psychiatry
Pays: England
ID NLM: 0111052

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 10 9 2020
medline: 19 8 2021
entrez: 9 9 2020
Statut: ppublish

Résumé

Alcohol use disorder and social anxiety disorder are interconnected disorders that commonly co-occur. We report the first trial to assess whether integrated treatment for social anxiety and alcohol use disorder comorbidity improves outcomes relative to standard alcohol-focussed treatment. Participants were recruited to a randomised controlled trial, and randomly allocated to one of two treatments, Integrated ( At 6-month follow-up, both conditions showed significant reductions in social anxiety and alcohol use disorder symptoms, and improved quality of life. There was no evidence of between-condition differences for alcohol outcomes, with mean consumption reduced by 5.0 (0.8) and 5.8 (1.0) drinks per day following Alcohol and Integrated treatments, respectively. Integrated treatment achieved greater improvements in social anxiety symptoms (mean difference = -14.9, 95% confidence interval = [-28.1, -1.6], These results suggest that integrated social anxiety and alcohol use disorder treatment enhances quality of life and social anxiety disorder symptom improvement, but not alcohol outcomes, compared to treatment focussed on alcohol use disorder alone.

Identifiants

pubmed: 32900220
doi: 10.1177/0004867420952539
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-220

Auteurs

Lexine A Stapinski (LA)

Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney, NSW, Australia.
The Matilda Centre of Research in Mental Health and Substance Use, The University of Sydney, Camperdown, NSW, Australia.

Claudia Sannibale (C)

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.

Mirjana Subotic (M)

Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney, NSW, Australia.

Ronald M Rapee (RM)

Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney, NSW, Australia.

Maree Teesson (M)

The Matilda Centre of Research in Mental Health and Substance Use, The University of Sydney, Camperdown, NSW, Australia.
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.

Paul S Haber (PS)

Discipline of Addiction Medicine, The University of Sydney, Camperdown, NSW, Australia.

Andrew J Baillie (AJ)

Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH